Suppr超能文献

抗菌药物+噬菌体联合检测方法的开发。

Development of antibacterial drug + bacteriophage combination assays.

作者信息

Attwood Marie, Griffins Pippa, Noel Alan, Josephs Theo, Adler Karen, Clokie Martha, MacGowan Alasdair

机构信息

Bristol Centre for Antimicrobial Research and Evaluation (BCARE), Infection Sciences, North Bristol NHS Trust, Pathology Quarter, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.

Department of Genetics and Genome Biology, University of Leicester, Leicester LE1 7RH, UK.

出版信息

JAC Antimicrob Resist. 2024 Jul 16;6(4):dlae104. doi: 10.1093/jacamr/dlae104. eCollection 2024 Aug.

Abstract

BACKGROUND

The best methods to study the interactions between phages and antibacterials are unclear. As laboratory methodologies used to assess conventional antibacterials are established, we assessed their ability to evaluate phage plus antibacterial.

METHODS

The efficacy of three characterized phages (UP17, JK08, 113) were tested on a 100 MDR . strains. The phages were assessed individually and in a 1:1:1 cocktail. In a phage microbial inhibitory concentration (PmIC) assay, a range of phage concentrations from 10 to 10 were inoculated with 5 × 10 bacteria/well in 96-well microtitre plates. The first fully lysed well was taken as the PmIC. Amikacin and meropenem MICs were determined by ISO 2776-1:2019 methods alone and in combination with a fixed phage concentration of 10/per well. Time-kill curves (TKCs) were conducted at fosfomycin concentrations of 133, 50 and 5 mg/L, with and without phage.

RESULTS

The PmIC values, in plaque-forming units (pfu)/mL, for individual phage titre were >10/>10 for UP17, 10/>10 for JK08, 10/>10 for 113 and 10/>10 for the 1:1:1 phage cocktail, all with a standard deviation (SD) of <0.05. Amikacin and meropenem MIC (SD) values were 2/8 mg/L (<0.05-9.2) and 0.12/8 mg/L (<0.05-8.7), respectively. The addition of UP17 to amikacin increased amikacin MICs >2-fold in 78 strains, with equivalent trends in 39 strains with JK08, 54 strains with 113 and 45 strains with phage cocktail. Meropenem MICs in the presence of phage were reduced >2-fold in 24 strains with UP17. Equivalent decreases were seen with 34 strains with JK08, 26 strains with 113 and 29 strains with the cocktail. In TKCs, the addition of phage suppressed regrowth.

CONCLUSIONS

Microbroth methodologies based on ISO 2776-1:2019 lend themselves to be viable options for phage assessment, alone or in combination with antibiotics. The reproducibility of PmIC and familiarity of the methodology described allows for laboratory validation for phage and antibiotic combinations.

摘要

背景

研究噬菌体与抗菌药物之间相互作用的最佳方法尚不清楚。由于用于评估传统抗菌药物的实验室方法已经确立,我们评估了这些方法评估噬菌体加抗菌药物的能力。

方法

对三种特征明确的噬菌体(UP17、JK08、113)在100株多重耐药菌株上进行了测试。分别单独以及以1:1:1的混合比例对噬菌体进行评估。在噬菌体微生物抑制浓度(PmIC)测定中,在96孔微量滴定板中接种一系列浓度从10到10的噬菌体,每孔接种5×10个细菌。第一个完全裂解的孔被视为PmIC。单独以及与每孔固定噬菌体浓度10联合使用时,通过ISO 2776-1:2019方法测定阿米卡星和美罗培南的最低抑菌浓度(MIC)。在有和没有噬菌体的情况下,分别在133、50和5mg/L的磷霉素浓度下进行时间-杀菌曲线(TKC)测定。

结果

各噬菌体滴度的PmIC值,以噬菌斑形成单位(pfu)/mL计,UP17大于10/大于10,JK08为10/大于10,113为10/大于10,1:1:1噬菌体混合液为10/大于10,所有标准偏差(SD)均<0.05。阿米卡星和美罗培南的MIC(SD)值分别为2/8mg/L(<0.05至9.2)和0.12/8mg/L(<0.05至8.7)。将UP17添加到阿米卡星中,在78株菌株中使阿米卡星的MIC增加了2倍以上,在39株使用JK08的菌株、54株使用113的菌株和45株使用噬菌体混合液的菌株中也有类似趋势。在24株使用UP17的菌株中,噬菌体存在时美罗培南的MIC降低了2倍以上。在34株使用JK08的菌株、26株使用113的菌株和29株使用混合液的菌株中也观察到了类似程度的降低。在TKC测定中,添加噬菌体抑制了细菌的再生长。

结论

基于ISO 2776-1:2019的微量肉汤法无论是单独用于噬菌体评估还是与抗生素联合使用,都是可行的选择。PmIC的可重复性以及所描述方法的熟悉程度使得该方法可用于噬菌体和抗生素组合的实验室验证。

相似文献

1
Development of antibacterial drug + bacteriophage combination assays.抗菌药物+噬菌体联合检测方法的开发。
JAC Antimicrob Resist. 2024 Jul 16;6(4):dlae104. doi: 10.1093/jacamr/dlae104. eCollection 2024 Aug.

本文引用的文献

5
The evolution of spectrum in antibiotics and bacteriocins.抗生素和细菌素的光谱演变。
Proc Natl Acad Sci U S A. 2022 Sep 20;119(38):e2205407119. doi: 10.1073/pnas.2205407119. Epub 2022 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验